Cost Effectiveness of Implantable Cardioverter Defibrillator Therapy versus Drug Therapy for Patients at High Risk of Sudden Cardiac Death

By Spath M.A.  

PharmacoEconomics, Vol. 20, Iss. 11, 2002-01 ,pp. : 727-738

Adis International

Access to resources Recommend Favorite

Cost-Effectiveness Analysis for Statin Therapies in the Primary Prevention of Coronary Heart Disease in Italy

By Berto P.  

Clinical Drug Investigation, Vol. 20, Iss. 2, 2000-08 ,pp. : 109-121

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Intensive Lipid-Lowering Treatment for Patients with Congestive Heart Failure and Coronary Heart Disease in the US

By Rosen Virginia M.  

PharmacoEconomics, Vol. 28, Iss. 1, 2010-01 ,pp. : 47-60

Adis International

Access to resources Recommend Favorite

Choice of Cost-Effectiveness Measure in the Economic Evaluation of Cholesterol-Modifying Pharmacotherapy: An Illustrative Example Focusing on the Primary Prevention of Coronary Heart Disease in Canada

By Morris S.  

PharmacoEconomics, Vol. 16, Iss. 2, 1999-08 ,pp. : 193-205

Adis International

Access to resources Recommend Favorite

Cost-Effectiveness of Specialized Multidisciplinary Heart Failure Clinics in Ontario, Canada

By Wijeysundera Harindra C.   Machado Márcio   Wang Xuesong   van der Velde Gabrielle   Sikich Nancy   Witteman William   Tu Jack V.   Lee Douglas S.   Goodman Shaun G.   Petrella Robert   O'Flaherty Martin   Capewell Simon   Krahn Murray  

Value in Health, Vol. 13, Iss. 8, 2010-12 ,pp. : 915-921

Blackwell Publishing

Access to resources Recommend Favorite